Replies to post #2297 on OpGen Inc (OPGN)

[mick]

$OPGN
Key Market Competitors:

Few of the major market competitors currently working in the global
liquid biopsy market are
Eurofins Scientific,
MDxHealth, CareDx Inc.,
Immucor, Inc.,
Thermo Fisher Scientific Inc.,
Menarini Silicon Biosystems,
QIAGEN,
GUARDANT HEALTH, INC,
Exact Sciences Corporation,
Myriad Genetics, Inc.,
LungLife AI, Inc.,
Bio-Rad Laboratories, Inc., N
atera, Inc.,
Trovagene,
Exosome Diagnostics,
Illumina, Inc.,
Genomic Health,
Biocept, Inc, RainDance Technologies Inc.,
BGI and
F. Hoffmann-La Roche Ltd among others.

Stock upgrades coming for those liquid biopsy companies that stand out and with the right patents, BIOCEPT should be priced at $4 minimum. HC Wainwright should step up